Ashwani Verma
Stock Analyst at UBS
(0.85)
# 1958
Out of 5,322 analysts
70
Total ratings
47.37%
Success rate
2.96%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
NBIX Neurocrine Bioscienc... | Maintains: Buy | 154 137 | 101.73 | 34.67% | 7 | Apr 4, 2025 | |
JAZZ Jazz Pharmaceuticals | Upgrades: Buy | 145 179 | 103.53 | 72.9% | 6 | Mar 7, 2025 | |
ALKS Alkermes | Upgrades: Neutral | n/a | n/a | n/a | 3 | Mar 4, 2025 | |
TEVA Teva Pharmaceutical ... | Maintains: Buy | 30 27 | 13.99 | 92.99% | 8 | Jan 30, 2025 | |
EXEL Exelixis | Maintains: Neutral | 30 34 | 36.46 | -6.75% | 2 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 22 14 | 8.29 | 68.88% | 2 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 415 475 | 292.78 | 62.24% | 4 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 106 114 | 63.17 | 80.47% | 2 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 56 | 29.14 | 92.18% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 4 2 | 1.08 | 38.89% | 4 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 55 54 | 21.11 | 155.8% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 83 79 | 131.87 | -40.09% | 5 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 23 | 14.36 | 60.17% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 107 105 | 103.92 | 1.04% | 2 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 28 | 32.2 | -13.04% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 76 81 | 34.38 | 135.6% | 2 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 61 92 | 37.85 | 143.06% | 4 | Jan 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 11 7 | 55.11 | -87.3% | 1 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 209 | 329.83 | -36.63% | 2 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 9 12 | 7.71 | 55.64% | 2 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 15 | 1.13 | 1227.43% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 137 71 | 116.3 | -38.95% | 3 | Aug 4, 2022 |